A study reports that in women with infertility or recurrent pregnancy loss with intrauterine pathology, MyoSure hysteroscopic tissue removal for normalization of the cavity supports subsequent conception and live birth
Doctors Vaishali Bhalani, Andrew Chang, Christen Adkins, Serena H. Chen and Michael Scheiber assess the effectiveness for improving the success of fertility treatments by resecting intrauterine pathology and normalizing the cavity prior to assisted reproductive technology (ART). The study found that in women with infertility or recurrent pregnancy loss with intrauterine pathology, MyoSure hysteroscopic tissue removal for normalization of the cavity supports subsequent conception and live birth. Below are details from their findings:
The only hysteroscopic tissue removal device with clinically proven fertility outcomes
